SERION ELISA agile

SARS-CoV-2

SERION ELISA agile SARS-CoV-2 IgA, IgG and IgM tests are qualitative and quantitative immunoassays for the detection of human antibodies in serum or plasma directed against SARS-CoV-2 and are recommended to support in the diagnosis of COVID-19 and as a complement to direct pathogen detection. In addition SERION ELISA agile SARS-CoV-2 IgG can be used for epidemiological studies.

Highlights

  • The utilization of the whole spike protein ensures an early and sensitive detection of SARS-CoV-2 IgG
  • Quantitative IgG test allows monitoring of immune response after infection or vaccination 
  • Expression of SARS-CoV-2 IgG antibody activity in standardized BAU/ml possible 
  • Detection of intrathecally synthesized IgG antibodies for CSF diagnostics 
  • Excellent correlation of the IgG test with neutralization assays 
  • Sensitive IgA and IgM antibody detection with high specificity ideal for determination of acute infections as complement to direct pathogen detection 
  • Quantitative eveluation of IgA antibody activities 
  • In house produced antigens guarantee relibale and reproducible results 

Products

SARS-CoV-2 IgA
SERION ELISA agile
ESR400A
SARS-CoV-2 IgG
SERION ELISA agile
ESR400G
SARS-CoV-2 IgM
SERION ELISA agile 
ESR400M